29 May 2009
Two types of unsafe drinker judged to have metabolic syndrome: typical metabolic syndrome or alcohol-related syndrome?
Hirokazu YokoyamaABCDEFG, Hiroshi HiroseBDEF, Ikuo SaitoDEFGMed Sci Monit 2009; 15(6): PH57-64 :: ID: 869662
Abstract
Background
Hypertension, hyperlipidemia, and hyperglycemia often occur in drinkers regardless of obesity. Thus, the diagnostic criteria of metabolic syndrome (MS) may judge some drinkers as having MS even when typical MS is absent.
Material and Method
To verify this, 1,346 Japanese men aged 40 to 65 were divided into four groups based on their statuses of MS and drinking habits, and various parameters were compared among them. According to the suggestion of the Japanese Ministry of Health, Labour and Welfare, daily ethanol consumption up to 20 grams was defined as safe drinking.
Results
The serum adiponectin level was significantly higher in unsafe drinkers with MS than in those without it, whereas drinking habits were shown not to affect it. Among subjects judged to have MS, the ALT/AST ratio (ALT/AST) was the most effective parameter to distinguish between safe and unsafe drinkers. When unsafe drinkers with MS were classified into two subgroups by ALT/AST, i.e. that of > or =0.9 or <0.9, levels of ALT and adiponectin significantly differed between them and levels in the former and the latter subgroups were comparable to those in safe drinkers with MS and in unsafe drinkers without MS, respectively. Although the prevalence of MS was higher in unsafe drinkers than in safe drinkers, it became equivalent to each other when the latter subgroup was eliminated.
Conclusions
In drinkers who satisfy the diagnostic criteria of MS, subjects whose characteristics are different from those of typical MS, but comparable to those of alcohol-related syndrome, co-exist. This over-diagnosis is most likely due to ethanol consumption.
Keywords: Metabolic Syndrome X - pathology, Aspartate Aminotransferases - metabolism, Alcohol Drinking - pathology, Alanine Transaminase - metabolism, Adiponectin - metabolism, Safety
Editorial
01 October 2024 : Editorial
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of ObesityDOI: 10.12659/MSM.946675
Med Sci Monit 2024; 30:e946675
In Press
Clinical Research
Anterior Disc Displacement and Cortication Patterns in the Temporomandibular JointMed Sci Monit In Press; DOI: 10.12659/MSM.945967
Review article
Lamotrigine: A Safe and Effective Mood Stabilizer for Bipolar Disorder in Reproductive-Age AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.945464
Clinical Research
Impact of Manual Sustained Inflation vs Stepwise PEEP on Pulmonary and Cerebral Outcomes in Carotid Endarte...Med Sci Monit In Press; DOI: 10.12659/MSM.944936
Clinical Research
Predicting Vaginal Delivery Success: Role of Intrapartum Transperineal Ultrasound Angle of Descent at a Sin...Med Sci Monit In Press; DOI: 10.12659/MSM.945458
Most Viewed Current Articles
17 Jan 2024 : Review article 6,056,505
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,846,289
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 693,590
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,892
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074